Ooni Koda
  1. Home
  2. /
  3. Newsfeed
  4. /
  5. Biofarm records a net profit of 77 million...

Biofarm records a net profit of 77 million lei in 2023, up 9% compared to 2022

March 4, 2024

Biofarm, (stock symbol BIO), one of the most important drug manufacturers in Romania, ended 2023 with a net profit of about 77 million lei, up 9% from the previous year and a turnover of approx. 280 million lei, according to preliminary results (unaudited).

 

"In 2023, we successfully implemented cost optimization strategies, focusing in particular on two of our company values: performance and end-consumer care. In doing so, we were able to identify effective ways to control our expenses, even in the context of rising raw material and packaging prices. The Consumer Healthcare category in Romania is becoming more and more competitive year by year, marked also by a slight decline in volumes in 2023 compared to 2022. However, we ended 2023 managing to consolidate our position on the market, with a positive evolution of the volume market share and to contribute positively on the quality of life of patients and consumers in Romania", said Cătălin Vicol, Biofarm CEO.

 

Biofarm continued to strengthen its market share in the Consumer Healthcare (CHC) segment, and ended 2023 in second position in terms of number of units sold.

 

The company dominates in value in 6 key categories across brands: Bixtonim, Triferment, Colebil, Extravalerianic, Carmol and Carbocit. In addition, Biofarm is the volume leader in no less than 8 categories, highlighting the outstanding performance of the brands Bixtonim, Colebil, Triferment, Sennalax, Extravalerianic, Carmol, Carbocit and Nervocalmin. These results confirm the success of Biofarm's approach and commitment to innovation. Through its achievements, the company continues to establish itself as a trusted player in Consumer Healthcare, offering effective and affordable solutions to consumers.

 

Biofarm has two drug factories in Bucharest and a product testing and development unit, and its portfolio of over 100 products covers the most important therapeutic areas of the Consumer Healthcare division (digestive & metabolic, respiratory & ORL, cardiovascular & circulatory, nervous system). Constant innovation in the development of new products is one of the fundamental elements for Biofarm's expansion and strengthening its position among the leaders in the pharmaceutical industry.

The information provided by KomuniK

The text of this article has been partially taken from the publication:
https://komunik.ro/biofarm-records-a-net-profit-of-77-million-lei-in-2023-up-9-compared-to-2022/
Read in full - click here
Exim Banca Romaneasca launches EURO debit card with PREMIUM benefits for individuals

Exim Banca Romaneasca diversifies its product portfolio and launches the Mastercard World card in EURO, a tool that enhances the payment experience for people who travel or work abroad, offering premium advantages, benefits, and rewards. The new EURO card from Exim Banca Romaneasca has as its main advantage the reduction of costs associated with transactions...

Report shows large-scale operation targeting Romanian diaspora voters on TikTok ahead of presidential elections

A report by cybersecurity company Refute uncovered a large-scale international influence operation targeting Romanian diaspora voters on TikTok ahead of the second round of Romania’s presidential elections on May 18. The report identifies approximately 32,500 TikTok videos containing slogans promoting the populist candidate George Simion and former candidate Călin Georgescu. Many of these videos are […]

Romania’s GDP stagnates in Q1 2025 with slowed 0.2% growth

Romania's gross domestic product (GDP) remained largely unchanged in the first quarter of 2025 compared to the previous quarter, according to flash estimates published on May 15 by the National Institute of Statistics (INS). The economy recorded a growth of 0.2% in gross series and 0.5% in seasonally adjusted series compared to the same quarter of […]

Expanded Iulius Mall Suceava opens after EUR 40 million investment

Iulius Mall Suceava has officially inaugurated its EUR 40 million expansion that transformed it into “the largest retail and entertainment hub in northern Romania,” according to the official announcement. Developed by IULIUS and Atterbury Europe, the project adds 16,500 sqm of new retail space, bringing the mall's total area to 60,000 sqm. The expansion introduces […]

Five new Romanian startups selected for EBRD Star Venture program

The European Bank for Reconstruction and Development (EBRD) announced the launch of the second edition of its Star Venture program in Romania this week, following a first edition in 2022. The program provides high-potential startups with business expertise and access to finance. After the round of applications, 10 promising startups were shortlisted to showcase their […]

How a dual education campus is taking shape in rural Romania

Non-profit BookLand started building last year a pre-university, dual-system campus in the village of Vultureşti, in southern Romania’s Argeş county. The campus will train pupils in various specializations, allowing them to work in industries ranging from hotels & restaurants to retail and food. More on how the project got off the ground and what it […]